Rhythm Biosciences Ltd has released a press release.
About the Genetype Acquisition
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- Completion of Genetype Risk Assessment Portfolio Acquisition
- RHY Acquires Genetype Genetic Risk Assessment Business
- Pause in Trading
- Market Update - All End of CY24 Milestones Attained
- Strong Demand in Share Placement to Raise $3.5 million
Later from Rhythm Biosciences
- Quarterly Activities Report and Appendix 4C - Dec24
- Genetype Commercial Integration Completion
- RHY Investor Webinar
- RHY Genetype Commercial Sales
- EGM - Investor Presentation
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences